Activity by Brian Kilen
Each company receives a $50,000 award and one year of consultation
ROCHESTER, Minn. â€“ On Oct. 1, Care at Hand and Wellpepper were selected as winners of the first-ever Mayo Clinic Think Big Challenge, which was sponsored by Mayo Clinic Center for Innovation (CFI), Mayo Clinic Ventures and AVIA Health Innovation. Winners will receive a $50,000 award and one year of consultation to help develop their innovative concepts for market.
The winners were chosen by attendees at Transform 2015, an annual gathering of industry leaders exploring the future of health and health care, which is hosted by the CFI. More than 130 applicants across the nation submitted ideas for the inaugural competition, and six finalist companies were selected for the final round of judging.
Care at Hand of San Francisco and Rockville, Maryland, won the Got Health Award, which focuses on ideas to enable healthy people to stay healthy.
Led by a team spanning medicine to engineering, Care at Hand is recognized for its work on an evidence-based smart survey and analytics platform that predicts and prevents hospitalizations using nonmedical workers. Forbes underscored Care at Handâ€™s leadership and investment in digital health technologies, saying Care at Hand is â€śblazing trails in telehealth and poised to become [a] household name.â€ť
Wellpepper of Seattle won the I Am Not My Disease Award, which focuses on helping people with chronic illnesses live better lives. [...]
Vitesse formed to identify and advance early stage biologic research in immunology, hematology and oncology
Deerfield, IL., Rochester, MN and South San Francisco, CA. â€” Baxter Ventures, the venture arm of Baxter International Inc. (NYSE:BAX), Mayo Clinic and Velocity Pharmaceutical Development, LLC (â€śVPDâ€ť) today announced the formation of Vitesse Biologics, LLC, (â€śVitesseâ€ť). Vitesse is a unique collaboration model initiated by Baxter Ventures to focus on the development of antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology. Following the spin-off of Baxter BioScience as Baxalta Incorporated, anticipated to take place by mid-2015, the Vitesse relationship will be managed by the planned venture arm, Baxalta Ventures, for the new company.
Baxter Media Contact:Â Kellie Hotz,Â (224) 948-5353, email@example.com
Baxter Investor Contact:Â Mary Kay Ladone, (224) 948-3371
Mayo Clinic Media Contact:Â Brian Kilen, (507) 284-5005, firstname.lastname@example.org
Velocity Media Contact:Â Leslie Loven, (415) 509-5110,Â Â email@example.com
Mayo Clinic Researcher Explains Five Individual Categories for Treatment of Obesity
ROCHESTER, Minn. â€“ Mayo Clinic researchers have identified five sub-categories of obesity in an effort to determine the most effective, individual treatments. More than two in three adults are considered to be overweight or obese and 17 percent of children are obese in the United States. Obesity is a costly health issue that increases the risk for heart disease, type 2 diabetes, and cancer, among others. The prevalence of obesity continues to rise despite education and efforts around diet, exercise, and drug/surgical therapy. In response, researchers asked how the gastrointestinal system affects obesity.
ROCHESTER, Minn. -- With Motherâ€™s Day being May 10Â and May being Womenâ€™s Health Month, Mayo Clinic offers expert guidance on fertility and conception.
Mayo Clinic expert Jani Jensen, M.D. is available to talk about the latest research and provide expert guidance for reporters writing articles on womenâ€™s health and fertility and conception.
She is co-author of the recently released Mayo Clinic Guide to Fertility and Conception. The comprehensive book provides answers and explanations for nearly every aspect of achieving a successful pregnancy. It covers lifestyle and nutrition, the intricacies of natural conception, common fertility problems, the latest medical treatments to help (including intrauterine insemination, in-vitro fertilization and donors), and information on special situations (fertility preservation, choosing single parenthood, same-sex couples and more). [...]
ROCHESTER, Minn.Â â€•Â Here are highlights from the AprilÂ issue ofÂ Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee.Â Mayo Clinic Health LetterÂ attribution is required. Include the following subscription information as your editorial policies permit: VisitÂ http://healthletter.mayoclinic.com/Â or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter April 2015Â (for journalists only).
Exercise eases depression symptoms
Increasing evidence shows that exercise can ease the symptoms of depression and anxiety. The April issue of Mayo Clinic Health Letter covers how exercise changes the brain and alleviates symptoms.
Depression is linked to abnormally low levels of certain neurotransmitters â€• chemicals in the brain that allow nerves to communicate with one another. Having less norepinephrine, dopamine and serotonin in the brain results in lower nerve stimulation than usual, contributing to feelings of sadness and emptiness, loss of interest in normal activities, tiredness, anxiety and trouble thinking.
Antidepressant medications work by increasing the levels of these chemicals and bringing them back to normal. Exercise does the same thing. In addition, new evidence shows that exercise sets into motion changes that protect the brain against the damaging effects of stress and enhance resilience to depression.
Exercise also has positive emotional and social effects that can help deal with stress and depression. Regular exercise helps:
ROCHESTER, Minn. â€“ Today Mayo Clinic announced two new applications for the Apple Watch that will help patients and providers manage schedules and visits. The Mayo Clinic app update is available on iTunes. The Synthesis app for providers is available to Mayo Clinic staff.
â€śIt is important that we interact with patients so that it seamlessly enhances their health care experiences. Whether this is through the Mayo Clinic app., remote monitoring, or the Apple watch, health consumer experience will continue to drive these technologies forward and Mayo Clinic will continue to lead with cutting edge technologies that benefit both our patients and
staff.â€ť says John T. Wald M.D., Medical Director, Mayo Clinic Public Affairs.
Journalists: Sound bites with Dr. Wald are available in the downloads.
MEDIA CONTACT: Brian Kilen, Mayo Clinic Public Affairs, 507-284-5005, firstname.lastname@example.org
AgreementÂ includes deployment of existing Optum360 revenue management services technology, development of new tools and delivery of services to increase patient satisfaction
Optum360 and Mayo Clinic announced today that they are collaborating to develop new revenue management services capabilities aimed at improving patient experiences and satisfaction while reducing administrative costs for health care providers.
Optum360 and Mayo Clinic will collaborate on enhancing and redesigning specific elements of the revenue cycle to increase efficiency while creating a convenient, accurate, transparent and personal experience for patients. A key focus is improving the interaction between the provider and payer by opening channels of communication early in the care process. The agreement includes a next-generation patient cost estimator, streamlining prior authorization/pre-certification, enhanced claims editing functions and administrative simplification of billing activities associated with pre-care packaged pricing.
â€śMayo Clinic and Optum360 have a shared vision of how a patient can best experience the revenueÂ cycle as part of their care,â€ť said Sandhya Pruthi, M.D., Mayo Clinic Medical Director for Patient Experience, Rochester. â€śThrough our work together, we will also address the unique needs and regulatory requirements of the market and deliver a superior patient experience.â€ť
MEDIA CONTACT: Brian Kilen, Mayo Clinic Public Affairs, 507-284-5005, email@example.com
ROCHESTER, Minn.Â â€•Â Here are highlights from theÂ March issue ofÂ Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee.Â Mayo Clinic Health LetterÂ attribution is required. Include the following subscription information as your editorial policies permit: VisitÂ http://healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text:Â Mayo Clinic Health Letter March 2015Â (for journalists only).
Pain medications might not work well for chronic pain â€• pain that doesnâ€™t go away with time. The March issue of Mayo Clinic Health Letter covers other types of medications and strategies to consider as part of long-term pain management.
Deciding on potential drug therapy for chronic pain usually involves analysis of the cause or causes of pain and knowing which type of drugs may be beneficial. Pain medications typically work well for pain resulting from headache, an injury or surgery. These same medications can lose their effectiveness over time, and some may even make pain worse or cause unacceptable side effects. Other options include: